A detailed history of Truadvice, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Truadvice, LLC holds 1,835 shares of LLY stock, worth $1.55 Million. This represents 0.43% of its overall portfolio holdings.

Number of Shares
1,835
Previous 2,030 9.61%
Holding current value
$1.55 Million
Previous $952,000 3.47%
% of portfolio
0.43%
Previous 0.37%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 13, 2023

SELL
$434.7 - $599.3 $84,766 - $116,863
-195 Reduced 9.61%
1,835 $985,000
Q2 2023

Aug 11, 2023

SELL
$350.74 - $468.98 $23,850 - $31,890
-68 Reduced 3.24%
2,030 $952,000
Q1 2023

May 01, 2023

BUY
$310.63 - $364.82 $226,449 - $265,953
729 Added 53.25%
2,098 $720,000
Q4 2022

Jan 20, 2023

SELL
$321.55 - $374.67 $321 - $374
-1 Reduced 0.07%
1,369 $0
Q3 2022

Nov 07, 2022

BUY
$296.48 - $337.87 $296 - $337
1 Added 0.07%
1,370 $483,000
Q2 2022

Aug 11, 2022

BUY
$278.73 - $327.27 $381,581 - $448,032
1,369 New
1,369 $419,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $805B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Truadvice, LLC Portfolio

Follow Truadvice, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Truadvice, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Truadvice, LLC with notifications on news.